Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05572606
Other study ID # 22-005844
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 30, 2022
Est. completion date September 2024

Study information

Verified date April 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to evaluate if hypnotherapy delivered electronically will help with bloating symptoms.


Description:

This study consists of seven pre-recorded hypnotherapy sessions that will be digitally delivered to patients on their own electronic devices via an existing digital platform provided by metaMe Health. metaMe Health is a company specialized in the delivery of digital hypnotherapy protocols. The sessions will be delivered to patients over twelve weeks in accordance with current gut-direct hypnotherapy practice. The patients must agree to have their consent and content delivered electronically and provide periodic outcomes by completing electronic symptom questionnaires. The whole study will last for 24 weeks: the initial 12-week treatment period and then an additional 12-week follow-up period.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 25
Est. completion date September 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Patients who meet Rome IV criteria for functional abdominal bloating/distension. - Patients who meet criteria for other Rome IV Disorder of Gut Brain Interaction diagnoses (including but not limited to irritable bowel syndrome, functional constipation, or functional dyspepsia) may be included if bloating is their predominant symptom. - Patients will be proficient in English language for comprehension of content. - Patients will have reliable access to digital delivery systems for content and questionnaire access via smartphone over the course of the study and follow up period. Exclusion criteria: - Patients with known prior diagnosis of small intestinal bacterial overgrowth (SIBO), gastroparesis, rumination syndrome, chronic intestinal pseudo-obstruction, advanced connective tissue diseases (e.g., scleroderma), and uncontrolled inflammatory bowel disease (IBD) will be excluded. - Patients with known disaccharide intolerances may be included if dietary restrictions are maintained during the duration of the study. - Patients who have a history of cognitive delay, traumatic brain injury with residual deficits, history of cerebral vascular accident with residual deficiencies in cognition, dementia, shall be excluded. - Patients with significant psychiatric illness with component of psychosis (schizophrenia, bipolar disorder), as well as severe untreated major depressive disorder with suicidal ideation will be excluded. - Patients with substance abuse disorders and drug addiction will be excluded. - Patients who are unlikely to comply or unlikely to benefit from psychotherapy-based interventions may be excluded at the direction of medical screening provider or principal investigator.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Hypnotherapy
Seven pre-recorded hypnotherapy sessions delivered over the course of twelve weeks via the patient's own electronic device such as a smartphone, tablet, or laptop. The length of the audio-recorded treatment sessions is expected to be approximately 40 minutes on average.

Locations

Country Name City State
United States Mayo Clinic Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in abdominal bloating severity Measured on a 0-100 scale using the bloating severity question of the the validated Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) Baseline, 6 weeks, 12 weeks, and 3 months
Secondary Bloating symptoms Assessed using the well validated upper GI symptom Severity Index (PAGI-SYM) Baseline, 6 weeks, 12 weeks, and 3 months
Secondary Change in perception of GI symptoms Measured using the self-reported Visceral Sensitivity Index (VSI) Baseline, 6 weeks, 12 weeks, and 3 months
Secondary Change in quality of life Assessed via the self-reported EuroQol-5D-5L (EQ-5D-5L) to evaluate mobility, self-care, usual activity, pain/discomfort, and anxiety/depression Baseline, 6 weeks, 12 weeks, and 3 months
Secondary Health care utilization Assessing the number of outpatient visits, portal messages, and procedures generated in three months Baseline, 12 weeks, and 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04684849 - Assessment and Validation of Electronic Gas and Bloating Diary
Recruiting NCT06122571 - A Clinical Trial to Evaluate the Effect of ConcenTrace Trace Mineral Drops on Gut Health N/A
Completed NCT02950012 - A Study to Evaluate OPTI-BIOMEā„¢ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population Phase 2
Recruiting NCT01070277 - Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea N/A
Completed NCT03548363 - Effect of Gingest on Symptoms of Dyspepsia N/A
Completed NCT05520411 - Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension N/A
Completed NCT01064661 - Pilot Study Studying Physiological Effects of Probiotic Pills in Patients With Abdominal Pain/Discomfort and Bloating N/A
Completed NCT03060733 - Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Completed NCT03060746 - Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Completed NCT02277431 - Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms Phase 2/Phase 3
Completed NCT04182178 - Long-term Follow-up After Surgical Treatment for GERD (Gastroesophageal Reflux Disease)
Completed NCT01099696 - Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating N/A
Completed NCT03134469 - Efficacy of Probiotics on Excessive Gas Accumulation N/A
Not yet recruiting NCT04243187 - Evaluation of Gastrointestinal Symptoms Following Chilean Native Beans Consumption N/A